Using empagliflozin in your patients with type 2 diabetes: considerations for daily patient care.

27 August 2017 (13:15 - 13:25)
Organised by:
Congress Presentation Part of: Improving cardiovascular outcomes in patients with type 2 diabetes: where does the evidence lead us? Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2017

About the speaker

Photo

University of Toronto, Toronto (Canada)

6 More presentations in this session

The Event

Event poster

ESC Congress 2017

27 August 2017 13:15 CET